Literature DB >> 20429999

Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation.

M Wiese-Posselt1, W Hellenbrand.   

Abstract

In July 2009, the German Standing Committee on Vaccination (STIKO) modified its recommendations for varicella and pertussis vaccination, based on newly available data on disease epidemiology, vaccine effectiveness (VE) and safety, and an evaluation of the feasibility of the recommended immunisation strategy. The recommendation for varicella vaccine now includes a routine two-dose schedule with the administration of the first dose at the age of 11 to 14 months and the second dose at the age of 15 to 23 months, with a minimum interval of four weeks between these doses. Furthermore, STIKO recommended adding a one-time pertussis booster to the adult vaccination schedule to expand the cocoon strategy in place since 2004. The recommendation of a booster vaccination with an acellular pertussis vaccine every 10 years for persons employed in the care of pre-school children and for healthcare personnel in paediatric, gynaecologic and obstetric health facilities was extended to persons employed in schools and in other institutions caring for older children, and to all healthcare personnel. These recommendations were based on available epidemiological data showing an increase in incidence from 7-10 cases per 100,000 inhabitants in 2002-2004 to over 30 by 2007. Moreover, the high burden of pertussis in infants at 94 hospitalised cases per 100,000 infants in 2007 suggested that the previous cocoon strategy was insufficient.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20429999

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  10 in total

1.  Hospitalizations for pertussis in Italy, 1999-2009: analysis of the hospital discharge database.

Authors:  Giovanni Gabutti; Maria Cristina Rota; Bernardo Bonato; Roberta Pirani; Giuliana Turlà; Alessandro Cucchi; Alessandra Cavallaro
Journal:  Eur J Pediatr       Date:  2012-07-13       Impact factor: 3.183

2.  Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study.

Authors:  Anita E Heywood; Han Wang; Kristine K Macartney; Peter McIntyre
Journal:  Bull World Health Organ       Date:  2014-06-13       Impact factor: 9.408

3.  Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.

Authors:  Ui Yoon Choi; Dong Ho Huh; Jong Hyun Kim; Jin Han Kang
Journal:  Hum Vaccin Immunother       Date:  2016-08-02       Impact factor: 3.452

Review 4.  Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses.

Authors:  Paolo Bonanni; Anne Gershon; Michael Gershon; Andrea Kulcsár; Vassiliki Papaevangelou; Bernard Rentier; Catherine Sadzot-Delvaux; Vytautas Usonis; Timo Vesikari; Catherine Weil-Olivier; Peter de Winter; Peter Wutzler
Journal:  Pediatr Infect Dis J       Date:  2013-07       Impact factor: 2.129

5.  Health care workers and pertussis: an underestimated issue.

Authors:  Sabine Wicker; Markus A Rose
Journal:  Med Klin (Munich)       Date:  2011-01-16

6.  [Vaccination in adult patients with chronic inflammatory rheumatic diseases].

Authors:  S Goldacker; A M Gause; K Warnatz
Journal:  Z Rheumatol       Date:  2013-09       Impact factor: 1.372

7.  Single-dose varicella vaccine effectiveness in school settings in China.

Authors:  Zhe Wang; Huili Yang; Keli Li; Aihua Zhang; Zijian Feng; Jane F Seward; Stephanie R Bialek; Chengbin Wang
Journal:  Vaccine       Date:  2013-07-08       Impact factor: 3.641

8.  Herpes zoster in Germany: quantifying the burden of disease.

Authors:  Bernhard Ultsch; Anette Siedler; Thorsten Rieck; Thomas Reinhold; Gérard Krause; Ole Wichmann
Journal:  BMC Infect Dis       Date:  2011-06-16       Impact factor: 3.090

9.  Attributes influencing parental decision-making to receive the Tdap vaccine to reduce the risk of pertussis transmission to their newborn - outcome of a cross-sectional conjoint experiment in Spain and Italy.

Authors:  Edouard Ledent; Giovanni Gabutti; Esther W de Bekker-Grob; Juan Luis Alcázar Zambrano; Magda Campins Martí; María Teresa Del Hierro Gurruchaga; María José Fernández Cruz; Giuseppe Ferrera; Francesca Fortunato; Pierfederico Torchio; Giorgio Zoppi; Christian Agboton; Walid Kandeil; Federico Marchetti
Journal:  Hum Vaccin Immunother       Date:  2019-04-15       Impact factor: 3.452

Review 10.  Pertussis: a review of disease epidemiology worldwide and in Italy.

Authors:  Giovanni Gabutti; Maria Cristina Rota
Journal:  Int J Environ Res Public Health       Date:  2012-12       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.